This company seems to have been delisted
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Reason: Filed for chapter 11 bankruptcy
Last recorded trade on: March 12, 2024
Source: https://www.fiercebiotech.com/biotech/athersys-files-bankruptcy-sells-assets-healios-wake-roke-cell-therapys-struggles
Athersys
ATHX
$0.01769
Share price
-33.50%
Change (1 day)
-98.94%
Change (1 year)
Categories
EPS for Athersys (ATHX)
EPS in 2023 (TTM): -$4.17
According to Athersys's latest financial reports the company's current EPS (TTM) is -$3.97. In 2022 the company made an earnings per share (EPS) of -$8.56 a decrease over its 2021 EPS that were of -$2.73.
EPS history for Athersys from 2005 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$4.17 | -51.27% |
| 2022 | -$8.56 | 213.94% |
| 2021 | -$2.73 | 395.24% |
| 2020 | -$0.55 | 44.83% |
| 2019 | -$0.38 | 61.11% |
| 2018 | -$0.24 | -37.93% |
| 2017 | -$0.38 | 70.59% |
| 2016 | -$0.22 | -19.05% |
| 2015 | -$0.28 | -25% |
| 2014 | -$0.37 | -48.15% |
| 2013 | -$0.71 | 10.2% |
| 2012 | -$0.64 | -18.33% |
| 2011 | -$0.79 | -0% |
| 2010 | -$0.79 | -25.93% |
| 2009 | -$1.06 | -15.63% |
| 2008 | -$1.26 | -96.39% |
| 2007 | -$34.82 | -61.05% |
| 2006 | -$89.39 | |
| 2005 | N/A |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | $18.55 | -567.00% | 🇺🇸 USA |
 | $2.44 | -161.39% | 🇺🇸 USA |
 | $5.20 | -231.02% | 🇺🇸 USA |
 | -$11.98 | 201.65% | 🇺🇸 USA |
 | $18.46 | -564.86% | 🇺🇸 USA |
 | $18.36 | -562.38% | 🇺🇸 USA |
 | $2.39 | -160.12% | 🇺🇸 USA |
 | $4.17 | -204.96% | 🇫🇷 France |